-
Guylian debuts new U.S. website, package design
ENGLEWOOD CLIFFS, N.J. — Looking to reach U.S. consumers, a Belgian chocolate brand has launched a new website and package design for its namesake treats.
Guylian said its new website and package highlights the iconic Belgium tradition, while offering U.S. customers new and unique ways to indulge its chocolates.
-
Keryx, Torii commence phase-3 trial for Zerenex in Japan
NEW YORK — A U.S. drug maker and its Japanese partner have started a late-stage clinical trial of a drug for treating elevated phosphate levels in the body, the two announced Monday.
Keryx Biopharmaceuticals and Torii Pharmaceutical, the pharmaceuticals subsidiary of Japan Tobacco, started a phase-3 trial of Zerenex (ferric citrate) in Japan for patients with hyperphosphatemia. The drug also is in phase-3 trials in the United States as a treatment for hyperphosphatemia in patients with end-stage kidney disease on dialysis.